Aquesta Bank (ATBK) 8.5500 $ATBK
Aquesta Financial Holdings, Inc (AQFH) - Announces Operating Results For the First Quarter of 2014
PR Newswire - Mon Apr 21, 9:21AM CDT
Aquesta Financial Holdings, Inc (stock symbol AQFH) and its Subsidiaries - including its major subsidiary Aquesta Bank ("Aquesta"
announced today operating income for the first quarter of 2014 (three month period ending March 31, 2014). For the first quarter, Aquesta had unaudited net income of $428,000 (17 cents per share) compared to net income of $347,000 for the first quarter of 2013 (14 cents per share)*.
Aquesta Announces Formation of Bank Holding Company March 31, 2014
PR Newswire - Mon Mar 31, 10:45AM CDT
Aquesta Bank (OTC-QB: ATBK) announced today that in accordance with prior shareholder approval, effective April 1, Aquesta Financial Holdings, Inc (stock symbol AQFH) is the new Bank Holding Company for Aquesta Bank and affiliates (including Aquesta Insurance Services, Inc). As of April 1, all shares of Aquesta Bank are exchanged on a one for one basis to shares of Aquesta Financial Holdings, Inc which will now be the sole shareholder of Aquesta Bank. Former shareholders of Aquesta Bank now own the exact same ownership interest in the new Bank Holding Company.
Aquesta Bank Announces Fourth Quarter Results
PR Newswire - Mon Jan 27, 7:38AM CST
Aquesta Bank and Subsidiaries ("Aquesta"- stock symbol ATBK) announced today its results for the fourth quarter ended December 31, 2013. For the fourth quarter, Aquesta had unaudited net income of $358,000 (14 cents per share) versus net income of $305,000 (12 cents per share*) for the fourth quarter of 2012. Unaudited net income for the year ended December 31, 2013 was $1.47 million (57 cents per share) versus net income for the year ended December 31, 2012 of $1.08 million (42 cents per share)*.
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain
PR Newswire - Thu Jan 23, 3:30PM CST
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today positive top-line results from its pivotal Phase 3 efficacy study of BEMA buprenorphine in opioid- "naive" subjects. BEMA buprenorphine is being developed for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy for an extended period of time in both patients who are opioid naive and opioid experienced.
Aquesta Bank Announces First Ever Cash Dividend
PR Newswire - Tue Nov 19, 3:04PM CST
Aquesta Bank and Subsidiaries ("Aquesta" (OTC Markets symbol ATBK) announced today that its Board of Directors has declared the payment of Aquesta's first ever cash dividend in the amount of 10 cents per share to shareholders of record as of November 29, 2013. The dividend is payable on December 13, 2013.
Aquesta Bank Announces Operating Results For the Second Quarter of 2013
PR Newswire - Wed Jul 17, 1:17PM CDT
Aquesta Bank (OTC-Pink: ATBK) and Subsidiaries ("Aquesta" announced today operating income for the second quarter of 2013 (three month period ending June 30, 2013). For the second quarter of 2013, Aquesta had unaudited net income of $360,000 (14 cents per share) compared to year ago net income of $304,000 for the second quarter of 2012 (12 cents per share)*.
Aquesta Bank Announces Operating Results For the First Quarter of 2013 & First Stock Dividend
PR Newswire - Wed Apr 17, 1:40PM CDT
Aquesta Bank (Symbol: ATBK) and Subsidiaries ("Aquesta" announced today operating income for the first quarter of 2013 (three month period ending March 31, 2013). For the first quarter of 2013, Aquesta had unaudited net income of $345,000 compared to net income of $146,000 for the first quarter of 2012. Net interest income for the first quarter of 2013 was comparable at $1.7 million for the same period of 2012. Aquesta Bank's total assets increased to $210.0 million at March 31, 2013 compared to $205.1 million at December 31, 2012 or an annualized growth rate of 10 percent.
Aquesta Financial Holdings, Inc (AQFH) - Announces Operating Results For the First Quarter of 2014
PR Newswire - Mon Apr 21, 9:21AM CDT
Aquesta Financial Holdings, Inc (stock symbol AQFH) and its Subsidiaries - including its major subsidiary Aquesta Bank ("Aquesta"
announced today operating income for the first quarter of 2014 (three month period ending March 31, 2014). For the first quarter, Aquesta had unaudited net income of $428,000 (17 cents per share) compared to net income of $347,000 for the first quarter of 2013 (14 cents per share)*. Aquesta Announces Formation of Bank Holding Company March 31, 2014
PR Newswire - Mon Mar 31, 10:45AM CDT
Aquesta Bank (OTC-QB: ATBK) announced today that in accordance with prior shareholder approval, effective April 1, Aquesta Financial Holdings, Inc (stock symbol AQFH) is the new Bank Holding Company for Aquesta Bank and affiliates (including Aquesta Insurance Services, Inc). As of April 1, all shares of Aquesta Bank are exchanged on a one for one basis to shares of Aquesta Financial Holdings, Inc which will now be the sole shareholder of Aquesta Bank. Former shareholders of Aquesta Bank now own the exact same ownership interest in the new Bank Holding Company.
Aquesta Bank Announces Fourth Quarter Results
PR Newswire - Mon Jan 27, 7:38AM CST
Aquesta Bank and Subsidiaries ("Aquesta"- stock symbol ATBK) announced today its results for the fourth quarter ended December 31, 2013. For the fourth quarter, Aquesta had unaudited net income of $358,000 (14 cents per share) versus net income of $305,000 (12 cents per share*) for the fourth quarter of 2012. Unaudited net income for the year ended December 31, 2013 was $1.47 million (57 cents per share) versus net income for the year ended December 31, 2012 of $1.08 million (42 cents per share)*.
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain
PR Newswire - Thu Jan 23, 3:30PM CST
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today positive top-line results from its pivotal Phase 3 efficacy study of BEMA buprenorphine in opioid- "naive" subjects. BEMA buprenorphine is being developed for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy for an extended period of time in both patients who are opioid naive and opioid experienced.
Aquesta Bank Announces First Ever Cash Dividend
PR Newswire - Tue Nov 19, 3:04PM CST
Aquesta Bank and Subsidiaries ("Aquesta"
(OTC Markets symbol ATBK) announced today that its Board of Directors has declared the payment of Aquesta's first ever cash dividend in the amount of 10 cents per share to shareholders of record as of November 29, 2013. The dividend is payable on December 13, 2013. Aquesta Bank Announces Operating Results For the Second Quarter of 2013
PR Newswire - Wed Jul 17, 1:17PM CDT
Aquesta Bank (OTC-Pink: ATBK) and Subsidiaries ("Aquesta"
announced today operating income for the second quarter of 2013 (three month period ending June 30, 2013). For the second quarter of 2013, Aquesta had unaudited net income of $360,000 (14 cents per share) compared to year ago net income of $304,000 for the second quarter of 2012 (12 cents per share)*. Aquesta Bank Announces Operating Results For the First Quarter of 2013 & First Stock Dividend
PR Newswire - Wed Apr 17, 1:40PM CDT
Aquesta Bank (Symbol: ATBK) and Subsidiaries ("Aquesta"
announced today operating income for the first quarter of 2013 (three month period ending March 31, 2013). For the first quarter of 2013, Aquesta had unaudited net income of $345,000 compared to net income of $146,000 for the first quarter of 2012. Net interest income for the first quarter of 2013 was comparable at $1.7 million for the same period of 2012. Aquesta Bank's total assets increased to $210.0 million at March 31, 2013 compared to $205.1 million at December 31, 2012 or an annualized growth rate of 10 percent. 
